New Release: Cardiac Fibrosis - Pipeline Review, H1 2014

198 views

Published on

Cardiac Fibrosis - Pipeline Review, H1 2014 @ http://www.researchmoz.us/cardiac-fibrosis-pipeline-review-h1-2014-report.html

This report provides comprehensive information on the therapeutic development for Cardiac Fibrosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
198
On SlideShare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

New Release: Cardiac Fibrosis - Pipeline Review, H1 2014

  1. 1. Cardiac Fibrosis - Pipeline Review, H1 2014 Cardiac Fibrosis - Pipeline Review, H1 2014 Summary Global Markets Directs, Cardiac Fibrosis - Pipeline Review, H1 2014, provides an overview of the Cardiac Fibrosiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Cardiac Fibrosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Cardiac Fibrosis and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides a snapshot of the global therapeutic landscape of Cardiac Fibrosis - The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Cardiac Fibrosis and enlists all their major and minor projects - The report summarizes all the dormant and discontinued pipeline projects - A review of the Cardiac Fibrosis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources - Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages - A detailed assessment of monotherapy and combination therapy pipeline projects - Coverage of the Cardiac Fibrosis pipeline on the basis of target, MoA, route of administration and molecule type - Latest news and deals relating related to pipeline products Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop strategic initiatives by understanding the focus areas of leading companies - Identify and understand important and diverse types of therapeutics under development for Cardiac Fibrosis - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Devise corrective measures for pipeline projects by understanding Cardiac Fibrosis pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline Table Of Contents table Of Contents 2 list Of Tables 4 list Of Figures 5 introduction 6 global Markets Direct Report Coverage 6 cardiac Fibrosis Overview 7 therapeutics Development 8 pipeline Products For Cardiac Fibrosis - Overview 8 pipeline Products For Cardiac Fibrosis - Comparative Analysis 9 cardiac Fibrosis - Therapeutics Under Development By Companies 10 cardiac Fibrosis - Therapeutics Under Investigation By Universities/institutes 12 cardiac Fibrosis - Pipeline Products Glance 13 clinical Stage Products 13 early Stage Products 14 Cardiac Fibrosis - Pipeline Review, H1 2014
  2. 2. unknown Stage Products 15 cardiac Fibrosis - Products Under Development By Companies 16 cardiac Fibrosis - Products Under Investigation By Universities/institutes 17 cardiac Fibrosis - Companies Involved In Therapeutics Development 18 merck & Co., Inc. 18 biolinerx, Ltd. 19 compugen Ltd. 20 digna Biotech, S.l. 21 promedior, Inc. 22 miragen Therapeutics, Inc. 23 fibrotech Therapeutics Pty. Ltd. 24 vida Therapeutics Inc. 25 ccrp Therapeutics Gmbh 26 cardiac Fibrosis - Therapeutics Assessment 27 assessment By Monotherapy Products 27 assessment By Target 28 assessment By Mechanism Of Action 31 assessment By Route Of Administration 34 assessment By Molecule Type 37 drug Profiles 39 card-024 - Drug Profile 39 product Description 39 mechanism Of Action 39 r&d Progress 39 p-17 - Drug Profile 41 product Description 41 mechanism Of Action 41 r&d Progress 41 disitertide - Drug Profile 42 product Description 42 mechanism Of Action 42 r&d Progress 42 cgen-856 - Drug Profile 44 product Description 44 mechanism Of Action 44 r&d Progress 44 prm-151 - Drug Profile 46 product Description 46 mechanism Of Action 46 r&d Progress 46 mgn-4220 - Drug Profile 48 product Description 48 mechanism Of Action 48 r&d Progress 48 pn1-ab - Drug Profile 49 product Description 49 mechanism Of Action 49 r&d Progress 49 ft-011 - Drug Profile 50 product Description 50 mechanism Of Action 50 r&d Progress 50 therapy For End-organ Damage - Drug Profile 51 product Description 51 mechanism Of Action 51 r&d Progress 51 tm-5441 - Drug Profile 52 product Description 52 mechanism Of Action 52 r&d Progress 52 cgen-856s - Drug Profile 53 product Description 53 mechanism Of Action 53 r&d Progress 53 drug For Fibrotic Diseases - Drug Profile 54 product Description 54 mechanism Of Action 54 r&d Progress 54 Cardiac Fibrosis - Pipeline Review, H1 2014
  3. 3. cyp11b2 Inhibitor Program - Drug Profile 55 product Description 55 mechanism Of Action 55 r&d Progress 55 cardiac Fibrosis - Recent Pipeline Updates 56 cardiac Fibrosis - Dormant Projects 60 appendix 61 methodology 61 coverage 61 secondary Research 61 primary Research 61 expert Panel Validation 61 contact Us 62 disclaimer 62 ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price. Contact: M/s Sheela, 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-997-4948 Email: sales@researchmoz.us Website: http://www.researchmoz.us/ Cardiac Fibrosis - Pipeline Review, H1 2014

×